Skip to main content
👋
Is this profile yours? Take control to keep your details current, set fees, and respond to reviews.
This page is aggregated from public sources. Claim this profile →
Dr Peter Dickinson
Trust score 8/100 Accepting new patients

Dr

Dr Peter Dickinson

Oncology

English
9,920+ Patients seen
2 Years in practice
2 Publications
1 Languages spoken

About

A leading specialist in the treatment of lung cancer, and the use of Stereotactic ablative radiotherapy (SABR) to treat metastatic cancer.

Dr Peter Dickinson has worked at Leeds Teaching Hospitals NHS Trust since 2013 and joined GenesisCare in 2023 as a Specialist Advisor to its Stereotactic Ablative Radiotherapy Clinical Reference Group.

He graduated from the University of Nottingham Medical School. He completed his training in Clinical Oncology in Nottingham and a technical radiotherapy fellowship at the Christie Hospital, Manchester. Dr Dickinson was appointed as consultant at Leeds Teaching Hospitals Trust in 2013. He was Clinical Lead for Clinical Oncology at Leeds Teaching Hospitals for two years and prior to this was Clinical Lead for Radiotherapy for six years. He is a member of Royal College of Radiologists Clinical Oncology Professional Practice Board

Dr Dickinson specialises in the use of Stereotactic Radiotherapy and in the treatment of thoracic malignancies with radiotherapy and systemic therapy. He uses Stereotactic radiotherapy to treat primary lung cancer and metastases in the following areas – spine, lung, lymph node, liver, bone and adrenal gland. He uses stereotactic radiotherapy to treat metastases in areas of the body which have been treated with radiotherapy previously.



Guided by the latest evidence, Dr Dickinson tailers treatment plans to meet each patient’s individual needs and circumstances. He is an effective communicator, takes time to answer patient’s questions, and ensures that patients fully understand their treatment plan and the aims of treatment.

Dr Dickinson has an active interest in clinical research and is Principle Investigator and Sub Investigator on a number of lung cancer clinical trials.

Dr Dickinson sees patients in the Nova Healthcare consultation rooms at St James' University Hospital, Leeds. Dr Dickinson is able to treat patients with radiotherapy at St James' Hospital in Leeds, and any GenesisCare radiotherapy centre in the UK.

“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”

— Dr Peter Dickinson

Education & training

  1. 2016–2022 MD · Medicine and Surgery
    Universitat de Barcelona (GB)
  2. 2022–2026 Residency · Oncology
    Universitat de València (GB)

Career & appointments

  1. 2026-09–2027-08 Junior consultant
    Universitat de Barcelona Teaching Hospital — Oncology

Licenses & insurance

Medical licenses

GB — Organización Médica Colegial de España (OMC)
#GB-927757 active · expires 2028-12-31

Board certifications

European Board of Oncology
#EB-F953D62C · issued 2027 · renewal 2037
Malpractice insurance: Allianz Professional · 4,000,000 EUR coverage · No claims on file

Procedures performed

ProcedureCodeLifetime count
GP consultation 99213 2,867
Annual physical exam 99395 1,373
Vaccination administration 90471 445
Minor procedure (skin) 17110 1,026

Services & pricing

ServiceDurationModalityPrice
New patient consultation (60m) 60 min in_clinic|telemed 180.00 EUR
Follow-up consultation (30m) 30 min in_clinic|telemed|phone 90.00 EUR
Vaccination administration 60 min in_clinic 180.00 EUR
Minor procedure (skin) 90 min in_clinic 450.00 EUR

Office, team & in practice

Peter Dickinson
HEADSHOT
Peter Dickinson in consultation
IN OFFICE
Peter Dickinson with the team
WITH TEAM
Peter Dickinson at a conference
CONFERENCE

Videos

introduction · 111s
Meet Peter Dickinson

Research & publications

h-index: 5 · i10: 10

  1. Validation of clinical scoring in Oncology
    Peter Dickinson, et al. · European Journal of Medicine, 2026
    DOI: 10.2010/euroclin.2026.0 · PMID: 37409871 · cited by 19
  2. Long-term follow-up of Oncology across GB
    Peter Dickinson, et al. · European Journal of Medicine, 2025
    DOI: 10.8887/euroclin.2025.1 · PMID: 33928168 · cited by 153

Invited talks

  • Practical updates in Oncology European Annual Congress (Oncology) · Vienna · 2024 · invited
  • Single-centre experience in Oncology National Society Meeting · · 2023 · oral abstract

Awards & memberships

Awards

  • 🏆 Top-rated Oncology — · EuroClinics Patient Choice · 2025 · regional

Society memberships

  • WONCA Europe — Family Doctors — Member · since 2027
  • national college of family doctors — Member · since 2027
  • European Union of Medical Specialists (UEMS) — Member · since 2027

Patient reviews

★ 0.00 0 verified reviews
Bedside Manner
0.05
Knowledge
0.08
Wait Time
3.80
Staff Friendliness
0.02
Ease Of Appointment
4.00
Value For Money
4.10
Would Recommend Pct
4
  • ★ 5 verified visit

    “Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.”

    — Anna B. · 2026-05-21

  • ★ 5 verified visit

    “Took time to listen and reviewed all my previous results. I would absolutely recommend.”

    — Marco V. · 2026-04-24

  • ★ 4 verified visit

    “Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.”

    — Helena F. · 2026-04-03

Articles by this doctor

  • Patient education Patient guide to Oncology
  • Awareness When should you see a oncology?

For international patients

Coordinator
Patient liaison · dr.peter.dickinson@euroclinics.example

Similar specialists

Browse all →